This week we talk about the recall of an anti-anxiety med; Possible withdrawal of Makena; New MS treatment approved; IUD approved for up to six years; and time of day when meds taken could affect CVD risk.

Topics:

Anxiety/OCD Cardiovascular Disease CHF and Arrhythmias General Psychiatry Miscellaneous Neurodegenerative Disorders Multiple Sclerosis Neurologic Disorders Obstetrics and Gynecology Weekly Dose